SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001486189-24-000049
Filing Date
2024-10-08
Accepted
2024-10-08 10:42:31
Documents
1
Period of Report
2024-09-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 3755
  Complete submission text file 0001486189-24-000049.txt   5343
Mailing Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645
Business Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645 855-226-9991
Cardio Diagnostics Holdings, Inc. (Issuer) CIK: 0001870144 (see all company filings)

IRS No.: 870925574 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 400 N. ABERDEEN ST., SUITE 900 CHICAGO IL 60642
Business Address
Dogan Meeshanthini (Reporting) CIK: 0001950789 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41097 | Film No.: 241359459